Certainly. I'll contrast it to SARS.
SARS we knew very little about. We didn't know it was airborne until the crisis was fundamentally over. In contrast, with COVID-19 we've done the genomic sequences in an incredibly fast turnaround. We have a variety of diagnostic tests and we have made them available in a very short time. However, unlike what happened with H1N1, we're not able to produce a vaccine in a similarly short time, because it's a novel coronavirus. It's not something we've seen in our environment before.
The international collaboration around knowledge sharing has been tremendous. The international publishing houses that control the scientific journals around the world have been very open in sharing all of that data, even pre-published materials, so I think the level of scientific advancements in this period of time has been tremendous, but we're always catching up because we've never been here before with this particular virus.